Similarly, inhibiting monocyte recruitment by blocking the CCL2–CCR2 axis induces compensatory recruitment of tumour-associated neutrophils [18], and CCL2 inhibition has also been associated with major increases in CCL2 levels and enhanced metastasis after therapy discontinuation [19, 20]. Here, CCL2 is linked to neoplasm.